Cancer Research and Treatment

Original Articles

Gastrointestinal Cancer

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer: Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha; Cancer Res Treat. 2021;53(4):1096-1103. Published online December 30, 2020; DOI: https://doi.org/10.4143/crt.2020.928

Purpose
Despite curative resection, the 5-year survival for patients with resectable pancreatic cancer is less than 20%. Recurrence occurs both locally and at distant sites and effective multimodality adjuvant treatment is needed.
Materials and Methods
Patients with curatively resected stage IB-IIB pancreatic adenocarcinoma were eligible. Treatment consisted of chemotherapy with gemcitabine 1,000 mg/m² on days 1 and 8 and cisplatin 60 mg/m² on day 1 every 3 weeks for two cycles, followed by chemoradiotherapy (50.4 Gy/28 fx) with weekly gemcitabine (300 mg/m²/wk), and then gemcitabine 1,000 mg/m² on days 1 and 8 every 3 weeks for four cycles. The primary endpoint was 1-year disease-free survival rate. The secondary endpoints were disease-free survival, overall survival, and safety.
Results
Seventy-four patients were enrolled. One-year disease-free survival rate was 57.9%. Median disease-free and overall survival were 15.0 months (95% confidence interval [CI], 11.6 to 18.4) and 33.0 months (95% CI, 21.8 to 44.2), respectively. At the median follow-up of 32 months, 57 patients (77.0%) had recurrence including 11 patients whose recurrence was during the adjuvant treatment. Most of the recurrences were systemic (52 patients). Stage at the time of diagnosis (70.0% in IIA, 51.2% in IIB, p=0.006) were significantly related with 1-year disease-free survival rate. Toxicities were generally tolerable, with 53 events of grade 3 or 4 hematologic toxicity and four patients with febrile neutropenia.
Conclusion
Adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiotherapy with gemcitabine and maintenance gemcitabine showed efficacy and good tolerability in curatively resected pancreatic cancer.

Citations

Citations to this article as recorded by

NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis
Xiao-Dong Huang, Yong-Wei Chen, Lv Tian, Li Du, Xiao-Chen Cheng, Yu-Xin Lu, Dong-Dong Lin, Feng-Jun Xiao
Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef
Efficacy of Cisplatin-Containing Chemotherapy Regimens in Patients of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
Obaid Ur Rehman, Eeshal Fatima, Zain Ali Nadeem, Arish Azeem, Jatin Motwani, Habiba Imran, Hadia Mehboob, Alishba Khan, Omer Usman
Journal of Gastrointestinal Cancer.2024; 55(2): 559. CrossRef
OTUB1/NDUFS2 axis promotes pancreatic tumorigenesis through protecting against mitochondrial cell death
Xiao-Dong Huang, Li Du, Xiao-Chen Cheng, Yu-Xin Lu, Qiao-Wei Liu, Yi-Wu Wang, Ya-Jin Liao, Dong-Dong Lin, Feng-Jun Xiao
Cell Death Discovery.2024;[Epub] CrossRef
Impact of obesity on pathological complete remission in early stage breast cancer patients after neoadjuvant chemotherapy: a retrospective study from a German University breast center
Johannes Felix Englisch, Alexander Englisch, Dominik Dannehl, Kenneth Eissler, Christian Martin Tegeler, Sabine Matovina, Léa Louise Volmer, Diethelm Wallwiener, Sara Y. Brucker, Andreas Hartkopf, Tobias Engler
Archives of Gynecology and Obstetrics.2024;[Epub] CrossRef
A Photothermal Therapy Study Based on Electrospinning Nanofibers Blended and Coated with Polydopamine Nanoparticles
Chunhong Sui, Yijia Luo, Xiao Xiao, Jiaxue Liu, Xiaotong Shao, Yingxue Xue, Cheng Wang, Wenliang Li
ChemistrySelect.2023;[Epub] CrossRef
Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
Da Eun Lee, Hyeon Woong Kang, So Yi Kim, Myeong Jin Kim, Jae Woong Jeong, Woosol Chris Hong, Sungsoon Fang, Hyung Sun Kim, Yun Sun Lee, Hyo Jung Kim, Joon Seong Park
Frontiers in Pharmacology.2022;[Epub] CrossRef
CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1
Yeting Lu, Shuping Zhou, Gong Cheng, Yi Ruan, Yuan Tian, Kaiji Lv, Shuo Han, Xinhua Zhou, Xiangya Ding
Journal of Oncology.2022; 2022: 1. CrossRef
Effects of Radiotherapy and Chemotherapy on Postoperative Prognosis of Patients Undergoing Radical Surgery for Pancreatic Cancer—Based on SEER Database Analysis
媛媛苏
Advances in Clinical Medicine.2022; 12(10): 9540. CrossRef
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
Alice Usai, Gregorio Di Franco, Margherita Piccardi, Perla Cateni, Luca Emanuele Pollina, Caterina Vivaldi, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente, Alfredo Falcone, Dimitri Giunchi, Alessandro Massolo, Vittoria Raffa, Luca Morelli
Cancers.2021; 13(16): 4131. CrossRef
Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21
Peng Chen, Zhiwei He, Jie Wang, Jian Xu, Xueyi Jiang, Yankun Chen, Xinyuan Liu, Jianxin Jiang
Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef

6,546 View
148 Download
10 Crossref

Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database: Yunghun You, Jin-Young Jang, Song Cheol Kim, Yoo-Seok Yoon, Joon Seong Park, Chol Kyoon Cho, Sang-Jae Park, Jae Do Yang, Woo Jung Lee, Tae Ho Hong, Keun Soo Ahn, Chi-Young Jeong, Hyeon Kook Lee, Seung Eun Lee, Young Hoon Roh, Hee Joon Kim, Hongbeom Kim, In Woong Han; Cancer Res Treat. 2019;51(4):1639-1652. Published online April 19, 2019; DOI: https://doi.org/10.4143/crt.2019.023

Abstract PDF PubReader ePub

Purpose
The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic neuroendocrine tumor (PNET) included several significant changes. We aim to evaluate this staging system compared to the 7th edition AJCC staging system and European Neuroendocrine Tumors Society (ENETS) system.
Materials and Methods
We used Korean nationwide surgery database (2000-2014). Of 972 patients who had undergone surgery for PNET, excluding patients diagnosed with ENETS/World Health Organization 2010 grade 3 (G3), only 472 patients with accurate stage were included.
Results
Poor discrimination in overall survival rate (OSR) was noted between AJCC 8th stage III and IV (p=0.180). The disease-free survival (DFS) curves of 8th AJCC classification were well separated between all stages. Compared with stage I, the hazard ratio of II, III, and IV was 3.808, 13.928, and 30.618, respectively (p=0.007, p < 0.001, and p < 0.001). The curves of OSR and DFS of certain prognostic group in AJCC 7th and ENETS overlapped. In ENETS staging system, no significant difference in DFS between stage IIB versus IIIA (p=0.909) and IIIA versus IIIB (p=0.291). In multivariable analysis, lymphovascular invasion (p=0.002), perineural invasion (p=0.003), and grade (p < 0.001) were identified as independent prognostic factors for DFS.
Conclusion
This is the first large-scale validation of the AJCC 8th edition staging system for PNET. The revised 8th system provides better discrimination compared to that of the 7th edition and ENETS TNM system. This supports the clinical use of the system.

Citations

Citations to this article as recorded by

Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors
Subin Heo, Hyo Jung Park, Hyoung Jung Kim, Jung Hoon Kim, Seo Young Park, Kyung Won Kim, So Yeon Kim, Sang Hyun Choi, Jae Ho Byun, Song Cheol Kim, Hee Sang Hwang, Seung Mo Hong
Cancer Imaging.2024;[Epub] CrossRef
Contemporary Approaches to the Surgical Management of Pancreatic Neuroendocrine Tumors
Akash Kartik, Valerie L. Armstrong, Chee-Chee Stucky, Nabil Wasif, Zhi Ven Fong
Cancers.2024; 16(8): 1501. CrossRef
Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study
Juwan Kim, Seung Soo Hong, Sung Hyun Kim, Ho Kyong Hwang, Chang Moo Kang
World Journal of Surgical Oncology.2024;[Epub] CrossRef
Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm
Sho Kiritani, Junichi Arita, Yuichiro Mihara, Rihito Nagata, Akihiko Ichida, Yoshikuni Kawaguchi, Takeaki Ishizawa, Nobuhisa Akamatsu, Junichi Kaneko, Kiyoshi Hasegawa
Surgery.2023; 173(2): 365. CrossRef
Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
Aleksander Kosmala, Sebastian E. Serfling, Wiebke Schlötelburg, Thomas Lindner, Kerstin Michalski, Andreas Schirbel, Takahiro Higuchi, Philipp E. Hartrampf, Andreas K. Buck, Alexander Weich, Rudolf A. Werner
Clinical Nuclear Medicine.2023; 48(1): 35. CrossRef
Recurrence and outcomes of non‐functional pancreatic neuroendocrine tumours post‐resection: an Australian retrospective, multicentre cohort study
Sean Lim, Lynn Chong, Saania Peeroo, Olukunle Onasanya, Evelyn He, Simon Banting, Daniel Croagh
ANZ Journal of Surgery.2023; 93(1-2): 160. CrossRef
Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma
Min Li, Linquan Wu, Shuaiwu Luo, Yaran Liu, Chi Sun, Enliang Li, Jiakun Wang, Bowen Li, Zhihao Huang, Jin Ge, Jun Lei, Fan Zhou, Wenjun Liao
European Journal of Surgical Oncology.2023; 49(7): 1217. CrossRef
A population-based nomogram to individualize treatment modality for pancreatic cancer patients underlying surgery
Xiao-Ya Shi, Yan Wang, Xuan Zhou, Meng-Li Xie, Qian Ma, Gan-Xin Wang, Jing Zhan, Yi-Ming Shao, Bai Wei
Scientific Reports.2023;[Epub] CrossRef
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
Alexander Weich, Sebastian E. Serfling, Wiebke Schlötelburg, Takahiro Higuchi, Philipp E. Hartrampf, Andreas Schirbel, Marieke Heinrich, Andreas K. Buck, Steven P. Rowe, Aleksander Kosmala, Rudolf A. Werner
Clinical Nuclear Medicine.2023; 48(7): 586. CrossRef
Lifestyle, clinical and histological indices-based prediction models for survival in cancer patients: a city-wide prospective cohort study in China
Ce Sun, Huan Xu, Suixiang Wang, Ke Li, Pengzhe Qin, Boheng Liang, Lin Xu
Journal of Cancer Research and Clinical Oncology.2023; 149(12): 9965. CrossRef
A Machine Learning Approach Using [18F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor
Yong-Jin Park, Young Suk Park, Seung Tae Kim, Seung Hyup Hyun
Molecular Imaging and Biology.2023; 25(5): 897. CrossRef
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors
Hebin Wang, Ding Ding, Tingting Qin, Hang Zhang, Jun Liu, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Feng Peng, Ruizhi He, Simiao Xu, Jikuan Jin, Yi Wu, Abu
HPB.2022; 24(5): 681. CrossRef
Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using data from the KOTUS-BP national database: overcoming selection bias and the necessity of definite indications
Hongbeom Kim, Jin Seok Heo, Chang Moo Kang, Ho Kyoung Hwang, Ho-Seong Han, Yoo-Seok Yoon, Joon Seong Park, Sung-Sik Han, Yong Hoon Kim, Hyeon Kook Lee, Young-Dong Yu, In Seok Choi, Jae Do Yang, Younghoon Roh, Seong-Ryong Kim, Junchul Chung, Sang Hwa Song,
HPB.2022; 24(10): 1804. CrossRef
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries
In Woong Han, Jangho Park, Eun Young Park, So Jeong Yoon, Gang Jin, Dae Wook Hwang, Kuirong Jiang, Wooil Kwon, Xuefeng Xu, Jin Seok Heo, De-Liang Fu, Woo Jung Lee, Xueli Bai, Yoo-Seok Yoon, Yin-Mo Yang, Keun Soo Ahn, Chunhui Yuan, Hyeon Kook Lee, Bei Sun,
Cancers.2022; 14(4): 1038. CrossRef
Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors
Xu-Feng Zhang, Feng Xue, Zheng Wu, Alexandra G. Lopez-Aguiar, George Poultsides, Eleftherios Makris, Flavio Rocha, Zaheer Kanji, Sharon Weber, Alexander Fisher, Ryan Fields, Bradley A. Krasnick, Kamran Idrees, Paula M. Smith, Cliff Cho, Megan Beems, Yi Ly
Annals of Surgery.2022; 275(6): e773. CrossRef
Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center
Sara Coelho, Cláudia Costa, Ana Paula Santos, Pedro Souteiro, Joana Oliveira, Júlio Oliveira, Isabel Azevedo, Isabel Torres, Maria José Bento
Endocrine Oncology.2022; 2(1): 32. CrossRef
Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors
Min Yang, Lin Zeng, Shengzhong Hou, Bole Tian, Shuguang Jin, Yi Zhang
Journal of Clinical Medicine.2022; 11(18): 5253. CrossRef
Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis
Jinghua Chen, Qichen Chen, Yiqiao Deng, Yujuan Jiang, Zhen Huang, Jianguo Zhou, Hong Zhao, Jianqiang Cai
Current Oncology.2022; 30(1): 344. CrossRef
Clinical value of 68Ga-DOTA-SSTR PET/CT in the diagnosis and detection of neuroendocrine tumors of unknown primary origin: a systematic review and meta-analysis
Huan Ma, Ying Kan, Ji-gang Yang
Acta Radiologica.2021; 62(9): 1217. CrossRef
Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach
Gabriel Fridolin Hess, Savas Deniz Soysal, Guillaume Nicolas, Martin Bolli, Christoph Johannes Zech, Alexandar Tzankov, Emanuel Christ, Michael Montemurro, Otto Kollmar, Tahsin Colak
Case Reports in Surgery.2021; 2021: 1. CrossRef
Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms
Hiromichi Iwaya, Yoshihiko Fukukura, Shinichi Hashimoto, Shiroh Tanoue, Machiko Kawahira, Makoto Hinokuchi, Toshihiro Fujita, Yuga Komaki, Shiho Arima, Fumisato Sasaki, Shuji Kanmura, Michiyo Higashi, Kiichi Tamada, Akio Ido
Pancreatology.2021; 21(4): 779. CrossRef
The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update
Xiaoyan Liao, Dongwei Zhang
Archives of Pathology & Laboratory Medicine.2021; 145(5): 543. CrossRef
Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors
Estela Regina Ramos Figueira, Julia Fray Ribeiro, Thiago Costa Ribeiro, Ricardo Jureidini, Guilherme Naccache Namur, Thiago Nogueira Costa, Telesforo Bacchella, Ivan Cecconello, Jose Celso Ardengh
Gastroenterology Research and Practice.2021; 2021: 1. CrossRef
New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [ ]
Min Wang, Ding Ding, Tingting Qin, Hebin Wang, Yahui Liu, Jianhua Liu, Jun Liu, Hang Zhang, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Ruizhi He, Simiao Xu,
Cancer Letters.2021; 518: 207. CrossRef
Ampullary Neuroendocrine Tumors: Insight into a Rare Histology
Samantha M. Ruff, Oliver Standring, Grace Wu, Anna Levy, Sandeep Anantha, Elliot Newman, Martin S. Karpeh, William Nealon, Gary B. Deutsch, Matthew J. Weiss, Danielle K. DePeralta
Annals of Surgical Oncology.2021; 28(13): 8318. CrossRef
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
Zu-Yi Ma, Yuan-Feng Gong, Hong-Kai Zhuang, Zi-Xuan Zhou, Shan-Zhou Huang, Yi-Ping Zou, Bo-Wen Huang, Zhong-Hai Sun, Chuan-Zhao Zhang, Yun-Qiang Tang, Bao-Hua Hou
World Journal of Gastroenterology.2020; 26(19): 2305. CrossRef
Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
Hong-Yu Chen, Ya-Liang Zhou, Yong-Hua Chen, Xing Wang, Hao Zhang, Neng-Wen Ke, Xu-Bao Liu, Chun-Lu Tan
World Journal of Gastroenterology.2020; 26(25): 3638. CrossRef
Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification
Lokesh Khanna, Srinivasa R. Prasad, Abhijit Sunnapwar, Sainath Kondapaneni, Anil Dasyam, Varaha S. Tammisetti, Umber Salman, Alia Nazarullah, Venkata S. Katabathina
RadioGraphics.2020; 40(5): 1240. CrossRef
Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors
Ashley L. Titan, Jeffrey A. Norton, Andrea T. Fisher, Deshka S. Foster, E. John Harris, David J. Worhunsky, Patrick J. Worth, Monica M. Dua, Brendan C. Visser, George A. Poultsides, Michael T. Longaker, Robert T. Jensen
JAMA Network Open.2020; 3(11): e2024318. CrossRef
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
Lingaku Lee, Tetsuhide Ito, Robert T Jensen
Expert Review of Anticancer Therapy.2019; 19(12): 1029. CrossRef

10,012 View
248 Download
32 Web of Science
30 Crossref

Trends in Gallbladder Cancer Incidence and Survival in Korea: Youngjun Wi, Hyeongtaek Woo, Young-Joo Won, Jin-Young Jang, Aesun Shin; Cancer Res Treat. 2018;50(4):1444-1451. Published online January 24, 2018; DOI: https://doi.org/10.4143/crt.2017.279

Abstract PDF Supplementary Material PubReader ePub

Purpose
The current study was undertaken to examine the trend in gallbladder cancer (GBC) incidence and survival in Korea.
Materials and Methods
GBC incidence data by histologic typewere obtained from the Korea Central Cancer Registry. Age-standardized incidence rates were calculated using the mid-year Korean population of 2000 as a standard population, and a joinpoint regression model was used to calculate the annual percent change (APC) in incidence rates. Incidence by Surveillance, Epidemiology and End Results (SEER) summary stage and by geographical areas and female-to-male incidence rate ratios was also described.
Results
The number of new GBC cases increased between 1999 and 2013. Nevertheless, the agestandardized incidence rate decreased by 0.5% per year in men (p < 0.01), whereas the incidence rate in women did not change significantly over the same period (APC, –0.2; p=0.6). The most common histologic type was adenocarcinoma in both sexes. Based on the SEER stage, the distant stage was the most frequent stage (41%), followed by the regional stage (37%). Ulsan (4.31/100,000 for men and 4.09/100,000 forwomen in 2009- 2013) and Gyeongsangnam-do (4.15/100,000 for men and 3.54/100,000 for women) showed the highest GBC incidence, whereas the lowest incidence was observed in Seoul and Gyeonggi-do. There were no significant sex differences in the incidence of GBC (femaleto-male incidence rate ratio, 0.96).
Conclusion
The overall incidence of GBC in Korea did not change significantly over the 15-year period. Incidence for men and women was similar. However, geographical variation was found.

Citations

Citations to this article as recorded by

Viscum album, as alternative and bridge to palliative chemotherapy in recurrent gallbladder cancer following laparoscopic radical cholecystectomy: a case report
Joonggyeong Shin, Eunsang Yim, Chang Moo Kang
Korean Journal of Clinical Oncology.2024; 19(2): 88. CrossRef
Association of female reproductive and hormonal factors with gallbladder cancer risk in Asia: A pooled analysis of the Asia Cohort Consortium
Aesun Shin, Sooyoung Cho, Sarah Krull Abe, Md Rashedul Islam, Md Shafiur Rahman, Eiko Saito, Sayada Zartasha Kazmi, Ryoko Katagiri, Melissa Merritt, Ji‐Yeob Choi, Xiao‐Ou Shu, Norie Sawada, Akiko Tamakoshi, Woon‐Puay Koh, Ritsu Sakata, Atsushi Hozawa, Jeo
International Journal of Cancer.2024; 155(2): 240. CrossRef
Establishment of a chronic biliary disease mouse model with cholecystoduodenal anastomosis for intestinal microbiome preservation
Yunseon Jang, Jung Yeon Kim, Song Yeon Han, Arum Park, So Jeong Baek, Gyurim Lee, Jihee Kang, Hyewon Ryu, Seok-Hwan Kim
World Journal of Gastroenterology.2024; 30(46): 4937. CrossRef
Lessons learnt from 1300 consecutive gallbladder cancer surgeries: Evolving role of peri-operative chemotherapy in the treatment paradigm
Shraddha Patkar, Swapnil Patel, Amit Gupta, Vikas Ostwal, Anant Ramaswamy, Nitin Shetty, Mahesh Goel
European Journal of Surgical Oncology.2023; 49(10): 107035. CrossRef
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
Sujin Park, Junsik Kim, Woncheol Jang, Kyoung-Mee Kim, Kee-Taek Jang
Journal of Pathology and Translational Medicine.2023; 57(2): 113. CrossRef
Radical surgery for stage IV gallbladder cancers: Treatment strategies in patients with limited metastatic burden
Shraddha Patkar, Swapnil Patel, Mufaddal Kazi, Mahesh Goel
Annals of Hepato-Biliary-Pancreatic Surgery.2023; 27(2): 180. CrossRef
EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer
Jung Ha Choi, Chang Moo Kang, Jeong Youp Park
World Journal of Surgical Oncology.2022;[Epub] CrossRef
Publication Trends of Research on Gallbladder Cancer During 2001–2021: A 20-Year Bibliometric Analysis
Wentao Sun, Wenze Wan, Zhihui Gao, Tao Suo, Sheng Shen, Houbao Liu
Frontiers in Oncology.2022;[Epub] CrossRef
A Case Report of Symptom Improvement with Recurrent Gallbladder Cancer Patients Treated with Korean Medicine-based Integrative Cancer Treatment
Eun-ju Ko, Sung-kuk Do, Ji-hye Park, Si-yeon Song, Yeon-weol Lee, Hwa-seung Yoo
The Journal of Internal Korean Medicine.2022; 43(3): 477. CrossRef
Target nursing care on anxiety and depression in patients with gallbladder cancer during perioperative period
Shuang Liu, Li Zhang, Xiu-e Guan, Lei Zhang, Rui Wang
Medicine.2022; 101(31): e29883. CrossRef
Epidemiological trends of gallbladder cancer in Australia between 1982 to 2018: A population-based study utilizing the Australian Cancer Database
Taha Mollah, Marc Chia, Luke C. Wang, Prasenjit Modak, Kirby R. Qin
Annals of Hepato-Biliary-Pancreatic Surgery.2022; 26(3): 263. CrossRef
A nomogram for predicting cancer-specific survival for elderly patients with gallbladder cancer
Chong Wen, Jie Tang, Tao Wang, Hao Luo
BMC Gastroenterology.2022;[Epub] CrossRef
Incidence and Preoperative Predictor Factors of Gallbladder Cancer Before Laparoscopic Cholecystectomy: a Systematic Review
Tarek Kellil, Mohamed Ali Chaouch, Emna Aloui, Mohamed Amine Tormane, Sahbi Khaled Taieb, Faouzi Noomen, Khadija Zouari
Journal of Gastrointestinal Cancer.2021; 52(1): 68. CrossRef
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
Hyehyun Jeong, Jae Ho Jeong, Kyu-Pyo Kim, Sang Soo Lee, Dong Wook Oh, Do Hyun Park, Tae Jun Song, Yangsoon Park, Seung-Mo Hong, Baek-Yeol Ryoo, Changhoon Yoo
Cancers.2021; 13(2): 161. CrossRef
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers
Ismaïl Hendaoui, Ahlem Lahmar, Luca Campo, Sihem Mebarki, Sandrine Bichet, Daniel Hess, Martin Degen, Nidhameddine Kchir, Leila Charrada-Ben Farhat, Rania Hefaiedh, Christian Ruiz, Luigi M. Terracciano, Richard P. Tucker, Lotfi Hendaoui, Ruth Chiquet-Ehri
Frontiers in Immunology.2021;[Epub] CrossRef
An overview on possible links between aflatoxin B1 exposure and gallbladder cancer
Jéssica Costa, Nelson Lima, Cledir Santos
Mycotoxin Research.2021; 37(3): 205. CrossRef
Gender Difference in Gallbladder Cancer: Focusing on the Clinical Characteristics, Treatment, and Prognosis of Korean Patients
Eui Joo Kim
The Korean Journal of Gastroenterology.2021; 78(1): 27. CrossRef
Urban-rural disparity in cancer mortality and changing trend in Tianjin, China, during 1999 and 2016
Wenlong Zheng, Hui Zhang, Dezheng Wang, Chong Wang, Shuang Zhang, Chengfeng Shen, Wei Li, Guohong Jiang
BMC Cancer.2021;[Epub] CrossRef
Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea
Jieun Jang, Dae-Sung Yoo, Byung Chul Chun
BMC Public Health.2021;[Epub] CrossRef
Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer
Ji Hye Kim, Kyungbin Kim, Misung Kim, Young Min Kim, Jae Hee Suh, Hee Jeong Cha, Hye Jeong Choi
Journal of Pathology and Translational Medicine.2020; 54(2): 154. CrossRef
Genetic landscape of gallbladder cancer: Global overview
Ravi Mehrotra, Sonam Tulsyan, Showket Hussain, Balraj Mittal, Sundeep Singh Saluja, Sandeep Singh, Pranay Tanwar, Asiya Khan, Milind Javle, Manal M. Hassan, Shubham Pant, Xabier De Aretxabala, Bhawna Sirohi, Preetha Rajaraman, Tanvir Kaur, G.K. Rath
Mutation Research/Reviews in Mutation Research.2018; 778: 61. CrossRef

9,647 View
245 Download
18 Web of Science
21 Crossref

Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution: Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang; Cancer Res Treat. 2017;49(2):473-483. Published online August 23, 2016; DOI: https://doi.org/10.4143/crt.2016.166

Abstract PDF Supplementary Material PubReader ePub

Purpose
This study was conducted to evaluate the long-term outcome in patients undergoing pancreaticoduodenectomy (PD) followed by adjuvant chemoradiotherapy for distal cholangiocarcinoma (DCC) in a high-volume center and to identify the prognostic impact of clinicopathologic factors.
Materials and Methods
A total of 132 consecutive patients who met the inclusion criteria were retrieved from the institutional database from January 1995 to September 2009. All patients received adjuvant treatments at a median of 45 days after the surgery. Median follow-up duration was 57 months (range, 6 to 225 months) for all patients and 105 months for survivors (range, 13 to 225 months).
Results
The 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) rates were 70.7%, 55.7%, 49.4%, and 48.1%, respectively. Univariate analysis revealed poorly differentiated (P/D) tumors and lymph node (LN) metastasis were significantly associated with DMFS and OS. Additionally, preoperative carbohydrate antigen 19-9 level was significantly correlated with DFS, LRRFS, and DMFS. Upon multivariate analysis for OS, P/D tumors (p=0.015) and LN metastasis (p=0.003) were significant prognosticators that predicted inferior OS. Grade 3 or higher late gastrointestinal toxicity occurred in only one patient (0.8%).
Conclusion
Adjuvant chemoradiotherapy after PD for DCC is an effective and tolerable strategy without significant side effects. During long-term follow-up, we found that prognosis of DCC was mainly influenced by histologic differentiation and LN metastasis. For patients with these risk factors, further research should focus on improving adjuvant strategies as well as other treatment approaches.

Citations

Citations to this article as recorded by

Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study
Peter LZ. Labib, Thomas B. Russell, Jemimah L. Denson, Mark A. Puckett, Fabio Ausania, Elizabeth Pando, Keith J. Roberts, Ambareen Kausar, Vasileios K. Mavroeidis, Ricky H. Bhogal, Gabriele Marangoni, Sarah C. Thomasset, Adam E. Frampton, Duncan R. Spaldi
European Journal of Surgical Oncology.2024; 50(6): 108353. CrossRef
Liver Transplantation for Cholangiocarcinoma
Nadine Soliman, Ashton A. Connor, Sudha Kodali, Rafik Mark Ghobrial
Digestive Disease Interventions.2024; 08(04): 239. CrossRef
Durable Response to Pembrolizumab and Lenvatinib in a Patient with Chemotherapy-refractory Cholangiocarcinoma
Winn Soe P, Huang Yiwu
Archives of Cancer Science and Therapy.2024; 8(1): 041. CrossRef
Impact of adjuvant therapy on outcomes after curative‐intent resection for distal cholangiocarcinoma
Jing‐Jing Hou, Shishir K. Maithel, Sharon M. Weber, George Poultsides, Christopher L. Wolfgang, Ryan C. Fields, Jin He, Charles Scoggins, Kamron Idrees, Perry Shen, Xu‐Feng Zhang, Timothy M. Pawlik
Journal of Surgical Oncology.2023; 127(4): 607. CrossRef
The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
Pavel Skalicky, Ondrej Urban, Jiri Ehrmann, Hana Svebisova, Dusan Klos, Jana Tesarikova, Cestmir Neoral, Katerina Knapkova, Martin Lovecek
Biomedical Papers.2022; 166(4): 386. CrossRef
Patterns of Regional Failure after Pancreaticoduodenectomy in Patients with Distal Extrahepatic Cholangiocarcinoma: Suggestion of the Clinical Target Volume for Elective Nodal Irradiation
W. Jung, Y. Park, K. Kim, H.J. Park, B.H. Kim
Clinical Oncology.2022; 34(1): e45. CrossRef
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
Mukul Vij, Yogesh Puri, Ashwin Rammohan, Gowripriya G, Rajesh Rajalingam, Ilankumaran Kaliamoorthy, Mohamed Rela
World Journal of Gastrointestinal Oncology.2022; 14(3): 607. CrossRef
The prognostic value of the lymph node ratio in patients with distal cholangiocarcinoma after curative intended surgery: A single-center retrospective study
Chaeyung Oh, Hee Joon Kim, Sang Hwa Song, Eun Kyu Park, Young Hoe Hur, Yang Seok Koh, Chol Kyoon Cho
Annals of Hepato-Biliary-Pancreatic Surgery.2022; 26(2): 168. CrossRef
Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
Charles Newton Odongo, Carlos Cabrera Dreque, David Mutiibwa, Felix Bongomin, Felix Oyania, Mvuyo Maqhawe Sikhondze, Moses Acan, Raymond Atwine, Fred Kirya, Martin Situma
Clinical and Experimental Gastroenterology.2022; Volume 15: 79. CrossRef
Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma
Marc Perez, Carsten Palnaes Hansen, Fernando Burdio, Gianluca Pellino, Adolfo Pisanu, Roberto Salvia, Marcello Di Martino, Mohammad Abu Hilal, Luca Aldrighetti, Benedetto Ielpo
Journal of the American College of Surgeons.2022; 235(5): 703. CrossRef
Surgical management of biliary malignancy
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica
Current Problems in Surgery.2021; 58(2): 100854. CrossRef
Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity‐matched National Cancer Database analysis
Sivesh K. Kamarajah, Filip Bednar, Clifford S. Cho, Hari Nathan
Cancer.2021; 127(8): 1266. CrossRef
Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma – A meta-analysis and systematic review
Ken Min Chin, Marcello Di Martino, Nicholas Syn, Benedetto Ielpo, Mohammad Abu Hilal, Brian K.P. Goh, Ye Xin Koh, Mikel Prieto
European Journal of Surgical Oncology.2021; 47(6): 1267. CrossRef
The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis
Won Ick Chang, Byoung Hyuck Kim, Hyun-Cheol Kang, Kyubo Kim, Kyung-Hun Lee, Do-Youn Oh, Hongbeom Kim, Wooil Kwon, Jin-Young Jang, Eui Kyu Chie
International Journal of Radiation Oncology*Biology*Physics.2021; 111(2): 395. CrossRef
Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas
V. Sallinen, J. Sirén, H. Mäkisalo, T. E. Lehtimäki, E. Lantto, A. Kokkola, A. Nordin
Scandinavian Journal of Surgery.2020; 109(3): 219. CrossRef
Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma
Weiwen Zhou, Liwen Qian, Yi Rong, Qiong Zhou, Jingjing Shan, Ping Li, Liming Shi, Hai Liu, Xiaonan Sun
Radiotherapy and Oncology.2020; 147: 111. CrossRef
Proposed Modification of Staging for Distal Cholangiocarcinoma Based on the Lymph Node Ratio Using Korean Multicenter Database
Yunghun You, Yong Chan Shin, Dong Wook Choi, Jin Seok Heo, Sang Hyun Shin, Naru Kim, Kee-Taek Jang, Hongbeom Kim, Chang-Sup Lim, Sun Hee Chang, Kang Min Han, In Woong Han
Cancers.2020; 12(3): 762. CrossRef
Combined treatment options for resectable common bile duct cancer patients
A. N. Polyakov, D. V. Podluzhny, Y. I. Patyutko, S. V. Chulkova, A. V. Egorova, I. S. Bazin, M. A. Shorikov, D. Yu. Frantsev, A. Yu. Syskova
Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2020; 25(3): 123. CrossRef
The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
Eleni Gkika, Maria A. Hawkins, Anca-Ligia Grosu, Thomas B. Brunner
Frontiers in Oncology.2020;[Epub] CrossRef
Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma
Xiaocheng Li, Huapeng Lin, Yu Sun, Jianping Gong, Huyi Feng, Jingkai Tu
Journal of Surgical Research.2019; 236: 2. CrossRef
PROGNOSTIC FACTORS FOR RESECTABLE COMMON BILE DUCT CANCER
A. Yu. Syskova, I. S. Stilidi, A. N. Polyakov
Research'n Practical Medicine Journal.2019; 6(2): 69. CrossRef
Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma
Sojun Hoshimoto, Shoichi Hishinuma, Hirofumi Shirakawa, Moriaki Tomikawa, Iwao Ozawa, Yoshiro Ogata
Oncology.2019; 96(6): 290. CrossRef
Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes
Hoon Sik Choi, Ki Mun Kang, Bae Kwon Jeong, Hojin Jeong, Yun Hee Lee, In Bong Ha, Tae Gyu Kim, Jin Ho Song
Radiation Oncology.2018;[Epub] CrossRef
Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort
Damien Bergeat, Olivier Turrini, Laetitia Courtin-Tanguy, Stéphanie Truant, Benjamin Darnis, Jean Robert Delpero, Jean-Yves Mabrut, Nicolas Regenet, Laurent Sulpice
Langenbeck's Archives of Surgery.2018; 403(6): 701. CrossRef

10,489 View
289 Download
22 Web of Science
24 Crossref

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma: Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jin-Young Jang, Sun Whe Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Ijin Joo, Sung W. Ha; Cancer Res Treat. 2015;47(2):274-281. Published online September 12, 2014; DOI: https://doi.org/10.4143/crt.2014.025

Abstract PDF PubReader ePub

Purpose
The purpose of this study was to evaluate the outcome of adjuvant chemoradiotherapy (CRT) after distal pancreatectomy (DP) in patients with pancreatic adenocarcinoma, and to identify the prognostic factors for these patients.
Materials and Methods
We performed a retrospective review of 62 consecutive patients who underwent curative DP followed by adjuvant CRT between 2000 and 2011. There were 31 men and 31 women, and the median age was 64 years (range, 38 to 80 years). Adjuvant radiotherapy was delivered to the tumor bed and regional lymph nodes with a median dose of 50.4 Gy (range, 40 to 55.8 Gy). All patients received concomitant chemotherapy, and 53 patients (85.5%) also received maintenance chemotherapy. The median follow-up period was 24 months.
Results
Forty patients (64.5%) experienced relapse. Isolated locoregional recurrence developed in 5 patients (8.1%) and distant metastasis in 35 patients (56.5%), of whom 13 had both locoregional recurrence and distant metastasis. The median overall survival (OS) and disease-free survival (DFS) were 37.5 months and 15.4 months, respectively. On multivariate analysis, splenic artery (SA) invasion (p=0.0186) and resection margin (RM) involvement (p=0.0004) were identified as significant adverse prognosticators for DFS. Also, male gender (p=0.0325) and RM involvement (p=0.0007) were associated with a significantly poor OS. Grade 3 or higher hematologic and gastrointestinal toxicities occurred in 22.6% and 4.8% of patients, respectively.
Conclusion
Adjuvant CRT may improve survival after DP for pancreatic body or tail adenocarcinoma. Our results indicated that SA invasion was a significant factor predicting inferior DFS, as was RM involvement. When SA invasion is identified preoperatively, neoadjuvant treatment may be considered.

Citations

Citations to this article as recorded by

Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study
Dominique Gantois, Théophile Guilbaud, Ugo Scemama, Edouard Girard, Olivier Picaud, Marine Lefevre, Myriam Elgani, Zeinab Hamidou, Vincent Moutardier, Paul Balandraud, Mircea Chirica, Louise Barbier, David Fuks, David Jérémie Birnbaum
Langenbeck's Archives of Surgery.2022; 407(1): 153. CrossRef
Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
Feng Yin, Mohammed Saad, Jingmei Lin, Christopher R Jackson, Bing Ren, Cynthia Lawson, Dipti M Karamchandani, Belen Quereda Bernabeu, Wei Jiang, Teena Dhir, Richard Zheng, Christopher W Schultz, Dongwei Zhang, Courtney L Thomas, Xuchen Zhang, Jinping Lai,
Gastroenterology Report.2021; 9(2): 139. CrossRef
Meta-analysis of recurrence pattern after resection for pancreatic cancer
M Tanaka, A L Mihaljevic, P Probst, M Heckler, U Klaiber, U Heger, M W Büchler, T Hackert
British Journal of Surgery.2019; 106(12): 1590. CrossRef
Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy
Ningyi Ma, Zheng Wang, Jiandong Zhao, Jiang Long, Jin Xu, Zhigang Ren, Guoliang Jiang
Medical Science Monitor.2017; 23: 2315. CrossRef
Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer—Population-Based Analysis with Propensity Score Matching
Yu Jin Lim, Kyubo Kim, Eui Kyu Chie, BoKyong Kim, Sung W. Ha
Journal of Gastrointestinal Surgery.2015; 19(12): 2183. CrossRef

11,769 View
92 Download
6 Web of Science
5 Crossref

First
Prev
Page of 1
Next
Last

Search